Yesterday, Eli Lilly and Company announced a $140 million project that will expand their Indianapolis insulin manufacturing operations by an additional 80,000-square-foot and will enable Eli Lilly to help meet the needs of people with diabetes and the growing demand for insulin cartridges in the U.S. Importantly, the construction project will employ between 250-350 workers and the finished operations will employ more than 100-full-time, high-skilled and specialized technicians, scientists and engineers.
Today’s manufacturers are pioneering the technology and innovation that touches each of our lives. Manufacturers are not just drivers of economic growth and job creation, but they are also leaders in the development of life-saving medical products.
John C. Lechleiter, Ph.D., Lilly’s chairman, president, and CEO summarized these efforts by saying, “the need in our country is great – and it is growing. This investment will help us to better meet that need while expanding our advanced manufacturing footprint in our home state – helping to strengthen Indiana’s bioscience industry.”